UTERINE LEIOMYOSARCOMA - A CASE REPORT
DOI:
https://doi.org/10.22159/ajpcr.2023.v16i2.46205Keywords:
Uterine leiomyosarcoma, Fibroid, Spindle cells, Atypia, Cancer, SarcomaAbstract
Leiomyomas are the most common mesenchymal neoplasms. Smooth muscle cells with variable amounts of fibrous stroma make up these benign tumors. The tumor occurs most frequently in uterus in 20–30% of women of reproductive age. Uterine leiomyosarcoma (uLMS/LMS) is a rare cancer originating from smooth muscle lining the walls of the uterus. We report a case of postmenopausal women of 65 years presented with retention urine, diagnosed as LMS of uterus on histopathology.
Downloads
References
Brooks SE, Zhan M, Cote T, Baquet CR. Surveillance, epidemiology, and end results analysis of 2677 cases of uterine sarcoma 1989-1999. Gynecol Oncol 2004;93:204-8. doi: 10.1016/j.ygyno.2003.12.029, PMID 15047237
Kaur K, Kaur P, Kaur A, Singla A. Uterine leiomyosarcoma: A case report. J Mid Life Health 2014;5:202-4. doi: 10.4103/0976- 7800.145175, PMID 25540573
Parker WH, Fu YS, Berek JS. Uterine sarcoma in patients operated on for presumed leiomyoma and rapidly growing leiomyoma. Obstet Gynecol 1994;83:414-8. PMID 8127535
Ricci S, Stone RL, Fader AN. Uterine leiomyosarcoma: Epidemiology, contemporary treatment strategies and the impact of uterine morcellation. Gynecol Oncol 2017;145:208-16. doi: 10.1016/j. ygyno.2017.02.019, PMID 28209496
Giunchi S, Perrone AM, Tesei M, Bovicelli A, De Crescenzo E, Dondi G, et al. Sonographic imaging in uterine sarcoma: A narrative review of literature. Gynecol Pelvic Med 2022;5:14. doi: 10.21037/gpm-21-20
Gadducci S, Cosio A, Romanini A. Genazzani AR. The management of patients with uterine sarcoma: A debated clinical challenge. Crit Rev Oncol Hematol 2008;65:129-42.
Bergman L, Beelen ML, Gallee MP, Hollema H, Benraadt J, van Leeuwen FE. Risk and prognosis of endometrial cancer after tamoxifen for breast cancer. Comprehensive cancer centres ALERT group assessment of liver and endometrial cancer risk following tamoxifen. Lancet 2000;356:881-7. doi: 10.1016/s0140-6736(00)02677-5, PMID 11036892
Wickerham DL, Fisher B, Wolmark N, Bryant J, Costantino J, Bernstein L, et al. Association of tamoxifen and uterine sarcoma. J Clin Oncol 2002;20:2758-60. doi: 10.1200/JCO.2002.20.11.2758,
PMID 12039943
Vellanki VS, Rao M, Sunkavalli CB, Chinamotu RN, Kaja S. A rare case of uterine leiomyosarcoma: A case report. J Med Case Rep 2010;4:222. doi: 10.1186/1752-1947-4-222, PMID 20649999
D’Angelo E, Prat J. Uterine sarcomas: A review. Gynecol Oncol 2010;116:131-9. doi: 10.1016/j.ygyno.2009.09.023, PMID 19853898
Sagae S, Yamashita K, Ishioka S, Nishioka Y, Terasawa K, Mori M, et al. Preoperative diagnosis and treatment results in 106 patients with uterine sarcoma in Hokkaido, Japan. Oncology 2004;67:33-9. doi: 10.1159/000080283, PMID 15459493
Rha SE, Byun JY, Jung SE, Lee SL, Cho SM, Hwang SS, et al. CT and MRI of uterine sarcoma and their mimickers. AJR Am J Roentgenol 2003;181:1369-74. doi: 10.2214/ajr.181.5.1811369, PMID 14573436
Hosh M, Antar S, Nazzal A, Warda M, Gibreel A, Refky B. Uterine sarcoma: Analysis of 13,089 cases based on surveillance, epidemiology, and end results database. Int J Gynecol Cancer 2016;26:1098-104. doi: 10.1097/IGC.0000000000000720, PMID 27177280
Ludovisi M, Moro F, Pasciuto T, Di Noi S, Giunchi S, Savelli L, et al. Imaging in gynaecological disease (15). Ultrasound Obstet Gynecol 2019;54:676-87. doi: 10.1002/uog.20270, PMID 30908820
Suzuki A, Aoki M, Miyagawa C, Murakami K, Takaya H, Kotani Y, et al. Differential diagnosis of uterine leiomyoma and uterine sarcoma using magnetic resonance images: A literature Review [review]. Healthcare (Basel) 2019;7:158. doi: 10.3390/healthcare7040158, PMID 31817500
Barral M, Placé V, Dautry R, Bendavid S, Cornelis F, Foucher R, et al. Magnetic resonance imaging features of uterine sarcoma and mimickers. Abdom Radiol (N Y) 2017;42:1762-72. doi: 10.1007/ s00261-017-1076-9, PMID 28246921
Santos P, Cunha TM. Uterine sarcomas: Clinical presentation and MRI features. Diagn Interv Radiol 2015;21:4-9. doi: 10.5152/dir.2014.14053. (PMC Free article). PMID 25347940
Abeler VM, Røyne O, Thoresen S, Danielsen HE, Nesland JM, Kristensen GB. Uterine sarcomas in Norway. A histopathological and prognostic survey of a total population from 1970 to 2000 including 419 patients. Histopathology 2009;54:355-64. doi: 10.1111/j.1365- 2559.2009.03231.x, PMID 19236512
Pelmus M, Penault-Llorca F, Guillou L, Collin F, Bertrand G, Trassard M, et al. Prognostic factors in early-stage leiomyosarcoma of the uterus. Int J Gynecol Cancer 2009;19:385-90. doi: 10.1111/ IGC.0b013e3181a1bfbc, PMID 19407564
Seagle BL, Sobecki-Rausch J, Strohl AE, Shilpi A, Grace A, Shahabi S. Prognosis and treatment of uterine leiomyosarcoma: A National Cancer Database study. Gynecol Oncol 2017;145:61-70. doi: 10.1016/j. ygyno.2017.02.012, PMID 28317559
Solmaz U, Dereli L, Demirtaş GS, Ekin A, Mat E, Gezer C, et al. An analysis of 37 patients with uterine leiomyosarcoma at a high-volume cancer center. Turk J Obstet Gynecol 2015;12:158-63. doi: 10.4274/tjod.33602, PMID 28913061
Mayerhofer K, Obermair A, Windbichler G, Petru E, Kaider A, Hefler L, et al. Leiomyosarcoma of the uterus: A clinicopathologic multicenter study of 71 cases. Gynecol Oncol 1999;74:196-201. doi: 10.1006/ gyno.1999.5436, PMID 10419731
Arend RC, Toboni MD, Montgomery AM, Burger RA, Olawaiye AB, Monk BJ, et al. Systemic treatment of metastatic/recurrent uterine leiomyosarcoma: A changing paradigm. Oncologist 2018;23:1533-45. doi: 10.1634/theoncologist.2018-0095, PMID 30139839
Kapp DS, Shin JY, Chan JK. Prognostic factors and survival in 1396 patients with uterine leiomyosarcomas: Emphasis on impact of lymphadenectomy and oophorectomy. Cancer 2008;112:820-30. doi: 10.1002/cncr.23245, PMID 18189292
Bell SW, Kempson RL, Hendrickson MR. Problematic uterine smooth muscle neoplasms. A clinicopathologic study of 213 cases. Am J Surg Pathol 1994;18:535-58. PMID 8179071
Devaud N, Vornicova O, Albiruni R, Razak A, Khalili K, Demicco EG, et al. Leiomyosarcoma: Current clinical management and future horizons. Surg Oncol Clin N Am 2022;31:527546. doi: 10.1016/j. soc.2022.03.011
Abeler VM, Nenodovic M. Diagnostic immunohistochemistry in uterine sarcomas: A study of 397 cases. Int J Gynecol Pathol 2011;30:236-43. doi: 10.1097/PGP.0b013e318200caff
Pautier P, Floquet A, Chevreau C, Penel N, Guillemet C, Delcambre C, et al. A single-arm multicentre phase II trial of doxorubicin in combination with trabectedin in the first-line treatment for leiomyosarcoma with long-term follow-up and impact of cytoreductive surgery. ESMO Open 2021;6:100209. doi: 10.1016/j.esmoop.2021.100209, PMID 34325109
Published
How to Cite
Issue
Section
Copyright (c) 2022 Heera Shenoy, Shivakumar, Abhilash, Fathima, Reslin A Khader, Nishi Kailash, Hiba Hashim
This work is licensed under a Creative Commons Attribution 4.0 International License.
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.
